SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-042632
Filing Date
2019-07-30
Accepted
2019-07-30 16:06:04
Documents
4
Period of Report
2019-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-16294_18k.htm 8-K 36806
2 EX-10.1 a19-16294_1ex10d1.htm EX-10.1 99242
3 EX-10.2 a19-16294_1ex10d2.htm EX-10.2 96138
4 EX-99.1 a19-16294_1ex99d1.htm EX-99.1 22806
  Complete submission text file 0001104659-19-042632.txt   256173
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38630 | Film No.: 19985536
SIC: 2834 Pharmaceutical Preparations